Clinical trials: Active Peptic Ulcer Disease/GI Bleeding

Bleeding Peptic Ulcers

Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding

• Completed
• Age: 18 years and older
• Medical device

The objective of this study is to show that Hemospray is effective in achieving initial hemostasis and documenting rate of further bleed when compared to standard of care.

Trial name

HALT (NCT01306864)

Testing

Hemospray Kit

Where

12 sites in Canada, Hong Kong and 2 more

Volunteers

67 people

Sponsor

Cook Group Incorporated